tiprankstipranks
Trending News
More News >
RegeneRx Biopharmaceuticals (RGRX)
OTHER OTC:RGRX
US Market

RegeneRx Biopharmaceuticals (RGRX) Income Statement

Compare
82 Followers

RegeneRx Biopharmaceuticals Income Statement

Last quarter (Q1 2023), RegeneRx Biopharmaceuticals's total revenue was $19.19K, a decrease of >-0.01% from the same quarter last year. In Q1, RegeneRx Biopharmaceuticals's net income was $-385.00K. See RegeneRx Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 76.76K$ 76.76K$ 76.76K$ 76.76K$ 69.67K
Gross Profit
$ 76.76K$ 70.12K$ 71.84K$ 76.70K$ 69.58K
Operating Expenses
$ 1.48M$ 1.41M$ 1.37M$ 1.34M$ 1.39M
Depreciation and Amortization
$ 183.00$ 1.33M$ 1.42K$ 1.42K$ 2.75K
EBITDA
$ -1.40M$ 56.00K$ -1.29M$ -1.25M$ -1.90M
Operating Income
$ -1.40M$ -1.33M$ -1.29M$ -1.26M$ -1.32M
Other Income/Expenses
$ -325.00K$ -269.00K$ -229.00K$ -142.00K$ -670.00K
Pretax Income
$ -1.73M$ -1.60M$ -1.52M$ -1.40M$ -1.99M
Net Income
$ -1.73M$ -1.60M$ -1.52M$ -1.40M$ -1.99M
Per Share Metrics
Basic EPS
$ -1.00$ -0.01$ -0.01$ -0.01$ -0.02
Diluted EPS
$ -1.00$ -0.01$ -0.01$ -0.01$ -0.02
Weighted Average Shares Outstanding
143.55M 138.59M 133.36M 130.97M 120.72M
Weighted Average Shares Outstanding (Diluted)
143.55M 138.59M 133.36M 130.97M 120.72M
Currency in USD

RegeneRx Biopharmaceuticals Earnings and Revenue History